Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Ho

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Journal of Surgical Oncology|September 29, 2021
Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancerTony K W Hung, Alan L Ho, David G Pfister
Clinical Nuclear Medicine|May 21, 2020
Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CTSimone Krebs, Iva Petkovska, Alan L Ho, et al.
Investigational New Drugs|January 25, 2013
The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysisAlyssa Fischer, Shenhong Wu, Alan L Ho, et al.
Anticancer Research|April 9, 2013
PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitorJayasree S Nair, Tahir Sheikh, Alan L Ho, et al.
Journal of Skin Cancer|August 20, 2014
Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapyRobert M Samstein, Alan L Ho, Nancy Y Lee, et al.
Head and Neck Pathology|October 16, 2021
Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic FeaturesMaelle Saliba, Abhinita S Mohanty, Alan L Ho, et al.
Oral Oncology|July 6, 2016
Unmet needs for patients with salivary gland cancerLara A Dunn, Alan L Ho, Scott A Laurie, et al.
Molecular Cancer Therapeutics|February 28, 2013
Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell deathGrazia Ambrosini, Elgilda Musi, Alan L Ho, et al.
Cancers|February 18, 2017
Androgen Receptor Signaling in Salivary Gland CancerMartin G Dalin, Philip A Watson, Alan L Ho, et al.
The Lancet. Oncology|December 15, 2010
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic reviewScott A Laurie, Alan L Ho, Matthew G Fury, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Journal of Surgical Oncology|September 29, 2021
Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancerTony K W Hung, Alan L Ho, David G Pfister
Clinical Nuclear Medicine|May 21, 2020
Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CTSimone Krebs, Iva Petkovska, Alan L Ho, et al.
Investigational New Drugs|January 25, 2013
The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysisAlyssa Fischer, Shenhong Wu, Alan L Ho, et al.
Anticancer Research|April 9, 2013
PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitorJayasree S Nair, Tahir Sheikh, Alan L Ho, et al.
Journal of Skin Cancer|August 20, 2014
Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapyRobert M Samstein, Alan L Ho, Nancy Y Lee, et al.
Head and Neck Pathology|October 16, 2021
Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic FeaturesMaelle Saliba, Abhinita S Mohanty, Alan L Ho, et al.
Oral Oncology|July 6, 2016
Unmet needs for patients with salivary gland cancerLara A Dunn, Alan L Ho, Scott A Laurie, et al.
Molecular Cancer Therapeutics|February 28, 2013
Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell deathGrazia Ambrosini, Elgilda Musi, Alan L Ho, et al.
Cancers|February 18, 2017
Androgen Receptor Signaling in Salivary Gland CancerMartin G Dalin, Philip A Watson, Alan L Ho, et al.
The Lancet. Oncology|December 15, 2010
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic reviewScott A Laurie, Alan L Ho, Matthew G Fury, et al.
Pageof 12